The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.

In a double-blind, placebo-controlled trial, we studied the effects of six months of growth hormone replacement in 24 adults with growth hormone deficiency. Most of the patients had acquired growth hormone deficiency during adulthood as a consequence of treatment for pituitary tumors, and all were receiving appropriate thyroid, adrenal, and gonadal hormone replacement. The daily dose of recombinant human growth hormone (rhGH) was 0.07 U per kilogram of body weight, given subcutaneously at bedtime. The mean (+/- SE) plasma concentration of insulin-like growth factor I increased from 0.41 +/- 0.05 to 1.53 +/- 0.16 U per liter during rhGH treatment. Treatment with rhGH had no effect on body weight. The mean lean body mass, however, increased by 5.5 +/- 1.1 kg (P less than 0.0001), and the fat mass decreased by 5.7 +/- 0.9 kg (P less than 0.0001) in the group treated with growth hormone; neither changed significantly in the placebo group. The basal metabolic rate, measured at base line and after one and six months of rhGH administration, increased significantly; the respective values were 32.4 +/- 1.4, 37.2 +/- 2.2, and 34.4 +/- 1.6 kcal per kilogram of lean body mass per day (P less than 0.001 for both comparisons). Fasting plasma cholesterol levels were lower (P less than 0.05) in the rhGH-treated group than in the placebo group, whereas plasma triglyceride values were similar in the two groups throughout the study. We conclude that growth hormone has a role in the regulation of body composition in adults, probably through its anabolic and lipolytic actions.

[1]  J. Durnin,et al.  A comparison of the fat-free mass of young adults estimated by anthropometry, body density and total body potassium content. , 1972, Clinical science.

[2]  A. Rogol,et al.  Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. , 1987, The Journal of clinical endocrinology and metabolism.

[3]  D. Waters,et al.  Body composition response to exogenous GH during training in highly conditioned adults. , 1988, Journal of applied physiology.

[4]  R. Hume,et al.  The relation of total body potassium to height, weight, and age in normal adults , 1972, Journal of clinical pathology.

[5]  R. Hesp,et al.  Total body potassium calibrations for normal and obese subjects in two types of whole body counter. , 1979, Physics in medicine and biology.

[6]  C. Grunfeld,et al.  The acute effects of human growth hormone administration on thyroid function in normal men. , 1988, The Journal of clinical endocrinology and metabolism.

[7]  Manson Jm,et al.  Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. , 1986 .

[8]  M. Carruthers,et al.  Free fatty acid estimation by a semi-automated fluorimetric method. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[9]  P. Collipp,et al.  Body composition changes in children receiving human growth hormone. , 1973, Metabolism: clinical and experimental.

[10]  Darrell M. Wilson,et al.  BIOSYNTHETIC METHIONYL HUMAN GROWTH HORMONE IS BIOLOGICALLY ACTIVE IN ADULT MAN , 1982, The Lancet.

[11]  P. Sönksen,et al.  Physiological Role of Growth Hormone in Adult Life , 1987, Acta paediatrica Scandinavica. Supplement.

[12]  N. Skakkebaek,et al.  BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS , 1989, The Lancet.

[13]  T. Merimee.  Familial combined hyperlipoproteinemia. Evidence for a role of growth hormone deficiency in effecting its manifestation. , 1980, The Journal of clinical investigation.

[14]  V. Marks,et al.  The Measurement of Insulin-Like Growth Factor I: Clinical Applications and Significance , 1986, Annals of clinical biochemistry.

[15]  G. Forbes,et al.  Human Body Composition , 1987, Springer New York.

[16]  P. Amer.  Control of lipolysis and its relevance to development of obesity in man , 1988 .

[17]  M. Vance,et al.  Growth hormone, 1988. , 1988, The Journal of clinical investigation.

[18]  E. Froesch,et al.  Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Halliday,et al.  Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. , 1987, Annals of surgery.

[20]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[21]  P. Björntorp,et al.  Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. , 1984, British medical journal.

[22]  J. Kopple,et al.  Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. , 1989, The Journal of clinical investigation.

[23]  M. Press,et al.  Growth hormone and metabolism. , 1988, Diabetes/metabolism reviews.

[24]  G. Forbes,et al.  Book Review: Human Body Composition: Growth, Aging, Nutrition, and Activity , 1988 .

[25]  L. Frohman,et al.  Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. , 1984, The New England journal of medicine.

[26]  H. Krebs,et al.  Enzymic determination of d(−)-β-hydroxybutyric acid and acetoacetic acid in blood , 1962 .

[27]  G. Bray.  Calorigenic effect of human growth hormone in obesity. , 1969, The Journal of clinical endocrinology and metabolism.

[28]  E. Froesch,et al.  Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Dahms,et al.  Endocrine function in human obesity. , 1981, Metabolism: clinical and experimental.

[30]  E. Kühn,et al.  Growth hormone stimulates the peripheral conversion of thyroxine into triiodothyronine by increasing the liver 5'-monodeiodinase activity in the fasted and normal fed chicken. , 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[31]  P. Henneman,et al.  Effects of human growth hormone in man. , 1960, The Journal of clinical investigation.

[32]  D. Clemmons,et al.  Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition. , 1988, The Journal of clinical endocrinology and metabolism.

[33]  P. Felig,et al.  Glucose and lipid homeostasis in the absence of human growth hormone. , 1971, The Journal of clinical investigation.